Medgenics, Inc. to Present Poster at European Society of Gene and Cell Therapy Congress to Highlight Results from Second-Generation Viral Vector
10/23/2013 7:44:58 AM
Medgenics, Inc. (NYSEMKT:MDGN)(AIM:MEDU, MEDG) (the “Company”), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, announces that a poster highlighting the Company’s second-generation EPODURE Biopump™ will be presented at the European Society of Gene and Cell Therapy Congress, taking place in Madrid October 25-28.
Help employers find you! Check out all the jobs and post your resume.
comments powered by